It comprises two operational divisions dedicated to serve the pharmaceutical industry: Pharmaceutical Systems with …
Collectively, the two own 0.7 percent of outstanding common stock, according to Thomson Reuters data ... its intention to replace the entire board of Obagi Medical Products Inc OMPI.O. Soon after that Obagi said it would be sold to Valeant …
Since then, the target of one-million SWHs has been reiterated and, at the most recent workshop, DoE acting deputy director-general for electricity Ompi Aphane explained that ... which excludes old housing stock and low-income housing.
As of this writing, he did not hold a position in any of the aforementioned securities. Article printed from InvestorPlace Media, http://investorplace.com/2013/03/biotech-movers-acadia-jumps-affymax-crashes/.
Cyprus may serve as a grave reminder of the global economy’s tenuous grip on stability, but U.S. investors have shown a willingness to overlook it as a blip, a passing tremor that the media and some pundits are blowing way out of proportion. …
Sees FY08 EPS of $0.52-$0.58, versus the consensus of $0.47. Obagi Medical Products (Nasdaq: OMPI) 14.8% …
The Australian national, who has been at the helm of WIPO since 2008, noted that the event would enable global stakeholders to take stock of what has been achieved and review plans going forward. He welcomed the implementation …